Please login to the form below

Not currently logged in
Email:
Password:

cardiovascular

This page shows the latest cardiovascular news and features for those working in and with pharma, biotech and healthcare.

FDA fast-tracks AstraZeneca’s Farxiga in heart failure

FDA fast-tracks AstraZeneca’s Farxiga in heart failure

The results were impressive – lead investigator John McMurray of the University of Glasgow said that Farxiga reduced the composite of cardiovascular death or worsening of heart failure by 26% (p< ... Farxiga is the first drug in the class to complete a

Latest news

More from news
Approximately 39 fully matching, plus 866 partially matching documents found.

Latest Intelligence

  • A roadmap to the successful treatment of Alzheimer’s disease A roadmap to the successful treatment of Alzheimer’s disease

    This would create a similar situation to cardiovascular disease where we use cholesterol as a biomarker and give statins in a preventative mode. ... To advance Alzheimer’s research, I believe that there are similar lessons to learn from the advances in

  • The evolution of real-world studies The evolution of real-world studies

    The UK is an ideal setting for population-based studies of diabetes because diabetes care is largely coordinated by the GP, and information about metabolic parameters, cardiovascular risk factors, diabetes

  • Cutting through the noise: CRISPR Cutting through the noise: CRISPR

    CRISPR libraries aren’t exclusively reserved for oncology, however. AstraZeneca has confirmed that it is applying the tech across other therapy areas, including cardiovascular, renal, metabolism and respiratory, with the continued

  • New models of NHS care – new models of pharma response? New models of NHS care – new models of pharma response?

    The region is now adopting population health models for musculoskeletal (MSK) respiratory disease, diabetes and cardiovascular disease.

  • The handover: Pfizer reshapes itself for a new era The handover: Pfizer reshapes itself for a new era

    She says the growth was led by its cardiovascular and anti-infective portfolios, which are meeting demand, and addressing previous low diagnosis and treatment by Pfizer expanding its coverage beyond the

More from intelligence
Approximately 0 fully matching, plus 71 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 54 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 2 fully matching, plus 45 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Atlantis Healthcare

Atlantis Healthcare is a global leader in optimising patient self-management. Established in 1996, we design, develop and implement scalable solutions...

Latest intelligence

Alzheimers incidence
A roadmap to the successful treatment of Alzheimer’s disease
Building on past research to learn more about the disease and how to treat it...
Article: Like, Like, Like: Harnessing the power of social media insights
...
Its Know Your Numbers week
Do you know yours?...

Infographics